Icahn School of Medicine At Mount Sinai

Icahn School of Medicine At Mount Sinai is a university in New York, United States that has taken part in 28 EU-funded projects since 2010, receiving €7.2M in EU funding.

EU funding received€7.2M
EU projects28
As coordinator0
Running now7
First EU project2010
Latest project2027
CountryUnited States
EU registration (PIC)985934482
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Icahn School of Medicine At Mount Sinai's own share of each project, not the project's full budget.

  • Horizon 2020€5.2M · 15 projects
  • Horizon Europe€1.3M · 8 projects
  • FP7 (2007 to 2013)€640k · 5 projects

Projects

28 EU-funded projects, newest first. Each links to the official record.

  • POPSCOREAssociated partner

    Leveraging POPulation genetic inferences to build actionable and equitable polygenic risk SCOREs for disease predictions

    Horizon Europe · 2027–2029 · Project on CORDIS ↗

  • DORIAN GRAYPartner

    Devising a personalized risk stratification and holistic management for prevention of cognitive impairment in patients with different cardiovascular phenotypes

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €150ktheir share
  • INTERCEPTPartner

    Verification and validation of a biomarker panel that identifies individuals at high risk to develop Crohn’s disease allowing INTERCEPTION of full-blown disease development

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €523ktheir share
  • CURE HEARTandBRAINAssociated partner

    CURE HEARTandBRAIN postdoctoral COFUND programme by CNIC

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

  • REMEMBERAssociated partner

    Decoding Gut microbiota-modulation of Memory

    Horizon Europe · 2023–2025 · Project on CORDIS ↗

  • CADASIL-iMATTRAssociated partner

    Investigation of Cerebral Autosomal Dominant Arteriopathy with Sub-cortical Infarcts and Leukoencephalopathy (CADASIL) using induced pluripotent stem cell modelling and targeted therapeutic research

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

  • Re-MENDPartner

    Building REsilience against MEntal illness during ENDocrine-sensitive life stages

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €154ktheir share
  • GlycanTriggerPartner

    GLYCANS AS MASTER TRIGGERS OF HEALTH TO INTESTINAL INFLAMMATION TRANSITION

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €500ktheir share
  • SBCVDPartner

    Role of stress-induced modulation of B cell function in cardiovascular disease

    Horizon 2020 · 2021–2024 · Project on CORDIS ↗

  • MICRO-COPSPartner

    Microglia Control of Physiological Brain States

    Horizon 2020 · 2021–2028 · Project on CORDIS ↗

    €2.5Mtheir share
  • AURORAPartner

    Actionable eUropean ROadmap for early-life health Risk Assessment of micro- and nanoplastics

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

    €252ktheir share
  • ENLIGHTENmePartner

    Innovative policies for improving citizens’ health and wellbeing addressing indoor and outdoor lighting

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €104ktheir share
  • EXPANSEPartner

    EXposome Powered tools for healthy living in urbAN SEttings

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €404ktheir share
  • RecruitPartner

    Origin and Function of Tumor-Associated Macrophages and Mesenchymal Stromal Cells in GBM Subtypes

    Horizon 2020 · 2019–2022 · Project on CORDIS ↗

  • ENDpoiNTsPartner

    Novel Testing Strategies for Endocrine Disruptors in the Context of Developmental NeuroToxicity

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €125ktheir share
  • Smart4HealthPartner

    Citizen-centred EU-EHR exchange for personalised health

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €1.4Mtheir share
  • CLIPPartner

    Comprehensive Lifestyle Intervention Project (CLIP)

    Horizon 2020 · 2017–2019 · Project on CORDIS ↗

  • HEPCIRPartner

    Cell circuits as targets and biomarkers for liver disease and cancer prevention

    Horizon 2020 · 2016–2022 · Project on CORDIS ↗

    €116ktheir share
  • RUBICONPartner

    Training network for Research on molecUlar and Biomechanical Interactions in CONnective tissue disorders

    Horizon 2020 · 2016–2019 · Project on CORDIS ↗

  • CARDIOTOXPartner

    Predicting Cardiotoxicity Induced by Kinase Inhibitors: From Systems Biology to Systems Pharmacology

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

  • REP-BIOTECHPartner

    European Joint Doctorate in Biology and Technology of Reproductive Health

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

  • EDC-MixRiskPartner

    Integrating Epidemiology and Experimental Biology to Improve Risk Assessment of Exposure to Mixtures of Endocrine Disruptive Compounds

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €266ktheir share
  • PRECeDIPartner

    Personalized PREvention of Chronic DIseases

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

  • REQUITEPartner

    Validating predictive models of radiotherapy toxicity to improve quality-of-life and reduce side-effects in cancer survivors

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €84ktheir share
  • INTERCONNECTPartner

    Global initiative on gene-environment interaction on diabetes/obesity risk

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €102ktheir share
  • IMAGEMENDPartner

    IMAging GEnetics for MENtal Disorders

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €393ktheir share
  • INSUP-CPartner

    Patient-centered palliative care pathways in advanced cancer and chronic disease

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €18ktheir share
  • HEPTROMICPartner

    Genomic predictors and oncogenic drivers in hepatocellular carcinoma

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €44ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • alzheimer
  • arteriosclerosis
  • breast cancer
  • carbohydrates
  • cardiology
  • cardiovascular diseases
  • cell signaling
  • crisis management
  • dementia
  • developmental biology
  • diabetes
  • drug discovery
  • eHealth

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime